A Study of an Implantable Miniature Telescope in Patients With With End-Stage AMD

A Prospective Multicenter Clinical Study of the Implantable Miniature Telescope* in Patients With Central Vision Impairment Associated With AMD: IMT-UK Protocol (*IMT by Dr. Isaac Lipshitz)

Evaluation of pre and post-implantation management of patients with end-stage age-related macular degeneration (AMD) who have been implanted with the implantable telescope (IMT) under CE Mark indicated use. This study is designed to evaluate in particular the optimal parameters for patient selection for use of this device in routine clinical practice.

Inclusion Criteria:

CE Mark approved indication of use which includes

• At least 55 years of age
• Bilateral visual impairment due to geographic atrophy or disciform scars
• Evidence of cataract

Exclusion Criteria:

• Active CNV (or 'wet' AMD)
• Prior cataract or refractive surgery in the study eye